Alerts will be sent to your verified email
Verify EmailROSEMER
|
Rose Merc
|
Welcure Drugs&Pharma
|
Ecofinity Atomix
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.86 % | 43.2 % | 3.44 % |
|
5yr average Equity Multiplier
|
1.47 | -0.38 | 3.65 |
|
5yr Average Asset Turnover Ratio
|
0.45 | 0.25 | 1.0 |
|
5yr Avg Net Profit Margin
|
-1.9 % | -80.17 % | 2.39 % |
|
Price to Book
|
0.53 | 0.31 | 1.34 |
|
P/E
|
9.3 | 1.19 | 15.18 |
|
5yr Avg Cash Conversion Cycle
|
45.47 Days | 2364.01 Days | 84.61 Days |
|
Inventory Days
|
253.79 Days | 20.66 Days | 24.73 Days |
|
Days Receivable
|
30.61 Days | 1232.42 Days | 80.14 Days |
|
Days Payable
|
-13.87 Days | 0.0 | 291.67 Days |
|
5yr Average Interest Coverage Ratio
|
71.94 | -2.67 | 307.45 |
|
5yr Avg ROCE
|
6.52 % | -7.19 % | 5.73 % |
|
5yr Avg Operating Profit Margin
|
-1.89 % | -81.01 % | -0.33 % |
|
5 yr average Debt to Equity
|
0.03 | -0.35 | 0.57 |
|
5yr CAGR Net Profit
|
28.47 % | -2.01 % | n/a |
|
5yr Average Return on Assets
|
-0.6 % | -1.33 % | 2.41 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.13 % | 0.0 | 37.83 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.59 % | 0.0 | -26.71 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Rose Merc
|
Welcure Drugs&Pharma
|
Ecofinity Atomix
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|